Q3 2024 ZimVie Inc Earnings Call Transcript
Key Points
- ZimVie Inc (ZIMV) reported a strong quarter with revenue of $103 million, driven by innovation across implants, biomaterials, and digital solutions.
- The company improved its manufacturing efficiency, reducing the cost of products sold both year-over-year and sequentially.
- ZimVie Inc (ZIMV) paid down $15 million in debt, reducing its gross debt to $220 million and net debt to $153 million.
- The digital portfolio, excluding iTero scanner sales, grew over 10% in the third quarter, with the RealGUIDE 5.4 software and Medit partnership driving growth.
- The Implant Concierge service grew 20% in the quarter, reflecting positive feedback and value provided to dentists by reducing labor and costs.
- Total third-party net sales decreased by 2% in reported rates and 2.2% in constant currency compared to the prior year period.
- Outside of the US, third-party net sales decreased by 6% on a reported basis, primarily due to timing of orders in Japan and Italy and a slower market in Spain.
- The company narrowed its full-year revenue guidance range to $450 million to $455 million, down from the previous range of $450 million to $460 million.
- SG&A expenses increased to $57.8 million from $55.8 million in the prior year, reflecting increased investment in the US direct sales force.
- The company faces macroeconomic pressures in Europe, impacting sales performance in the region.
Good afternoon, and welcome to ZimVie's third-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Marissa Bych from Gilmartin Group for introductory disclosures.
Thank you all for joining today's call. Earlier today, ZimVie released financial results for the quarter ended September 30, 2024. A copy of the press release is available on the company's website, zimvie.com, as well as on sec.gov. Before we begin, I'd like to remind you that management will make comments during this call that include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties.
Please refer to the company's most recent periodic report filed with the SEC and subsequent SEC filings for a detailed discussion of these risks and uncertainties.
In addition, the discussion on this call will include certain non-GAAP financial measures. Reconciliations of these measures to the most directly
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
